Najeebullah Bangash
Interventional Cardiology · Royal Oak, MINPI 1083276026
Payments from drug & device makers
Across 100 payments — averaging $72.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- ZOLL Circulation Inc$1K
- Abbott$621
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$613
- AstraZeneca$607
- Abiomed$301
- plus $2K from 22 others
What the payments were for
- Travel & lodging$1,85026%
- Food & beverage$5,10370%
- Education$3014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 19 | $1,769 |
| ZOLL Circulation Inc | 6 | $1,336 |
| Abbott | 6 | $621 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $613 |
| AstraZeneca | 11 | $607 |
| Abiomed | 4 | $301 |
| Boehringer Ingelheim | 2 | $240 |
| Shockwave Medical, Inc | 3 | $198 |
| Amgen | 2 | $176 |
| Stryker | 2 | $173 |
| Cardiva Medical, Inc. | 4 | $141 |
| Johnson & Johnson | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Lantheus Medical Imaging, Inc. | 4 | $102 |
| Chiesi USA, Inc. | 2 | $95 |
| Novo Nordisk | 2 | $88 |
| Bridgebio Pharma, Inc. | 1 | $82 |
| Medtronic | 2 | $70 |
| Inari Medical, Inc. | 2 | $54 |
| Cordis US CORP. | 3 | $52 |
| Kestra Medical Technology Services, Inc. | 2 | $52 |
| Terumo Medical Corporation | 2 | $50 |
| Actelion Pharmaceuticals US, Inc. | 1 | $40 |
| Teleflex LLC | 2 | $37 |
| Philips North America LLC | 1 | $37 |
| Spectrawave, Inc | 1 | $31 |
| Novartis | 1 | $24 |
| Penumbra, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TherOx DS2 Console$1,256
- Catheter$1,256
- Downstream Cartridge$1,256
- GENERAL - THERAPIES$954
- COROFLOW$381
- AVVIGO Guidance System$293
- JARDIANCE$240
- OPTIS$175
- FLOWTRIEVER CATHETER, S$146
- CT THROMBECTOMY SYSTEM KIT$146
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$146
- Impella$135
- GENERAL VASCULAR ACCESS$128
- XARELTO$125
- CAMZYOS$125
How this compares
$7,254 in reported general payments places this provider in the 45th percentile of 187 interventional cardiology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $14,886 |
| FarxigaDapagliflozin Propanediol | 12 | $14,814 |
| JardianceEmpagliflozin | 12 | $14,131 |
| Rosuvastatin Calcium | 31 | $515 |
| Metoprolol Succinate | 32 | $420 |
| Losartan Potassium | 21 | $412 |
| Atorvastatin Calcium | 43 | $383 |
| Spironolactone | 12 | $200 |
| Amlodipine Besylate | 13 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $607 | $14,81412 claims |
| Boehringer IngelheimJardiance | $240 | $14,13112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 187 interventional cardiology providers in Michigan.
Other interventional cardiology in Royal Oak
- Ryan MadderRoyal Oak$239K
- Amir KakiDetroit$2.3M
- William MerhiGrand Rapids$2M
- Shukri DavidSouthfield$1.6M
- Qaiser ShafiqSouthgate$1.3M
- Marcel ZughaibSouthfield$1.2M
- Jason RicciPetoskey$1.1M
- Khaldoon AlaswadDetroit$1.1M
- Paul GrossmanAnn Arbor$1.1M
- Tamam MohamadDetroit$960K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.